Tag: Dr K Anandkumar
Indian Immunologicals holds scientific conclave on pandemic preparedness & vaccine innovation
The objective of this conclave was to ideate, explore and collaborate on the learnings of the pandemic, and to build a more robust & resilient health care system
Dr K. Anand Kumar awarded honorary doctorate by Saveetha Institute of...
The doctorate was in recognition of Dr Anand Kumar’s exemplary contributions to the life sciences industry
Indian Immunologicals receives regulatory approval for Measles-Rubella vaccine
This vaccine has been proven through extensive human clinical trials to be immunogenic and safe for people of 9 months to 49 years